AU2020904714A0 - Treatment of covid-19 with rebamipide - Google Patents

Treatment of covid-19 with rebamipide

Info

Publication number
AU2020904714A0
AU2020904714A0 AU2020904714A AU2020904714A AU2020904714A0 AU 2020904714 A0 AU2020904714 A0 AU 2020904714A0 AU 2020904714 A AU2020904714 A AU 2020904714A AU 2020904714 A AU2020904714 A AU 2020904714A AU 2020904714 A0 AU2020904714 A0 AU 2020904714A0
Authority
AU
Australia
Prior art keywords
rebamipide
covid
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2020904714A
Inventor
Michael Lionel Selley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xenexus Pharmaceuticals Pty Ltd
Original Assignee
Xenexus Pharmaceuticals Pty Ltd
Filing date
Publication date
Application filed by Xenexus Pharmaceuticals Pty Ltd filed Critical Xenexus Pharmaceuticals Pty Ltd
Publication of AU2020904714A0 publication Critical patent/AU2020904714A0/en
Pending legal-status Critical Current

Links

AU2020904714A 2020-12-17 Treatment of covid-19 with rebamipide Pending AU2020904714A0 (en)

Publications (1)

Publication Number Publication Date
AU2020904714A0 true AU2020904714A0 (en) 2021-01-21

Family

ID=

Similar Documents

Publication Publication Date Title
EP3937964A4 (en) Treatment of oncogene-driven cancers
EP4157251A4 (en) Methods of antipathogenic treatment
EP4055040A4 (en) Compositions and methods for treatment of cancer with lekti
EP4096703A4 (en) Therapeutic uses of tirzepatide
EP4051805A4 (en) Methods of treatments based upon molecular response to treatment
EP4017493A4 (en) Methods of treatment using bcn057 and bcn512
EP4114396A4 (en) Methods of administering elagolix
AU2020904714A0 (en) Treatment of covid-19 with rebamipide
EP4097297A4 (en) Treatment of bacterial nanocellulose
EP4051260A4 (en) Methods and compositions for treatment of cancer
EP4037650A4 (en) Treatment of alcoholic hepatitis
EP4065106A4 (en) Methods of treating hiv-1 infection
EP3958876A4 (en) Compositions and methods for treatment of cancer
EP3876934A4 (en) Use of tivozanib to treat subjects with refractory cancer
EP3911358A4 (en) Methods and compositions for treatment of cancer
AU2020902574A0 (en) Treatment for covid-19 with rebamipide
EP3837355A4 (en) Methods and compositions for treatment of solid cancers and microbial infection
AU2021900740A0 (en) Combination Methods of Treatment
AU2021903030A0 (en) Methods of treatment
AU2021902512A0 (en) Methods of treatment
AU2021900789A0 (en) Methods of treatment
AU2020903332A0 (en) Methods of treatment
AU2020902585A0 (en) Methods of treatment
AU2020900580A0 (en) Methods of Treatment
EP4034125A4 (en) Treatment of excitotoxicity-related conditions